AUTHOREA
Log in Sign Up Browse Preprints

loading page

Differentiation Syndrome In Patients With Acute Promyelocytic Leukemia
  • +2
  • Nusiba Elamin,
  • Farah Rashid,
  • Mohammad Suhail Afana,
  • Honar Cherif,
  • mohamed yassin
Nusiba Elamin
Hamad Medical Corporation

Corresponding Author:[email protected]

Author Profile
Farah Rashid
Hamad Medical Corporation
Author Profile
Mohammad Suhail Afana
Hamad Medical Corporation
Author Profile
Honar Cherif
Hamad Medical Corporation
Author Profile
mohamed yassin
HMC NCCCR
Author Profile

Abstract

A 48-year-old male diagnosed with Acute promyelocytic leukemia (APL) started on all-trans retinoic acid and arsenic trioxide, developed typical symptoms of differentiation syndrome, and improved dramatically on steroids. Hence, any APL patient started on chemotherapy, needs to be monitored closely for developing differentiation syndrome and to start steroid upon suspicion.

Peer review status:ACCEPTED

18 Aug 2022Submitted to Clinical Case Reports
Show details
Hide details
22 Aug 2022Submission Checks Completed
22 Aug 2022Assigned to Editor
27 Aug 2022Reviewer(s) Assigned
17 Sep 2022Review(s) Completed, Editorial Evaluation Pending
17 Sep 2022Editorial Decision: Revise Minor
28 Oct 20221st Revision Received
29 Oct 2022Submission Checks Completed
29 Oct 2022Assigned to Editor
29 Oct 2022Review(s) Completed, Editorial Evaluation Pending
29 Oct 2022Editorial Decision: Revise Minor
31 Oct 20222nd Revision Received
01 Nov 2022Submission Checks Completed
01 Nov 2022Assigned to Editor
01 Nov 2022Review(s) Completed, Editorial Evaluation Pending
13 Nov 2022Editorial Decision: Accept